ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 955 filers reported holding ISHARES TR in Q4 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $336,297 | -5.4% | 2,750 | -1.8% | 0.06% | 0.0% |
| Q2 2023 | $355,488 | +98101.1% | 2,800 | 0.0% | 0.06% | -1.8% |
| Q1 2023 | $362 | -1.6% | 2,800 | 0.0% | 0.06% | -5.1% |
| Q4 2022 | $368 | -99.8% | 2,800 | +64.7% | 0.06% | +90.3% |
| Q1 2022 | $222,000 | -14.3% | 1,700 | 0.0% | 0.03% | -13.9% |
| Q4 2021 | $259,000 | -19.8% | 1,700 | -15.0% | 0.04% | -18.2% |
| Q3 2021 | $323,000 | -6.1% | 2,000 | -4.8% | 0.04% | -2.2% |
| Q2 2021 | $344,000 | +8.9% | 2,100 | 0.0% | 0.04% | +7.1% |
| Q1 2021 | $316,000 | -32.8% | 2,100 | -32.3% | 0.04% | -42.5% |
| Q4 2020 | $470,000 | +11.9% | 3,100 | 0.0% | 0.07% | -16.1% |
| Q3 2020 | $420,000 | -0.9% | 3,100 | 0.0% | 0.09% | -15.5% |
| Q2 2020 | $424,000 | +26.9% | 3,100 | 0.0% | 0.10% | +15.7% |
| Q1 2020 | $334,000 | -10.7% | 3,100 | 0.0% | 0.09% | +39.1% |
| Q4 2019 | $374,000 | +29.4% | 3,100 | +6.9% | 0.06% | +23.1% |
| Q3 2019 | $289,000 | – | 2,900 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |